Where Will Oracle Years? Two-Year Outlook for Stock
Oracle is racing to reinvent itself as an AI-enabled cloud platform, funding AI infrastructure with debt while juggli...
Will Risk Parity Protect Retirees During Bear Markets
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articles
Osl HK Announces USDKG Listing, Strengthens Asia’s Digital Asset Drive
OSL HK has listed USDKG, a gold-backed stablecoin issued by a state-supervised issuer, on its licensed exchange. The ...
Elon Musk Admits Underestimated AI Lead, Take Note Today
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Quant Funds Just Suffered a Rough Momentum Rout This Week
A swift rotation out of momentum bets hammered quant trading desks, delivering the year’s sharpest rout for the secto...
SpaceX Falls Back to $135; Raymond James Sees Moonshot
SpaceX is hovering around its $135 IPO price as investors digest post-debut dynamics. One broker, Raymond James, argu...
Frontier Capital Makes Stride: A Big Bet on Stride Stock
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
IonQ Stock Surged Today: Key Drivers Behind the Jump
IonQ stock surged today after the company issued a revenue forecast that beat expectations, sparking a rally in the q...
Okta Stock Surged 52-Week to New High on AI Push Today
Investors cheered a decisive move higher as Okta unveiled AI-powered growth opportunities. The stock touched a new 52...
Is the Lululemon Buy? Bull Bear Thesis After Earnings
Lululemon beat on Q4 revenue and EPS, but 2026 guidance signals slower growth and ongoing governance questions. Inves...
Bitcoin vs Ethereum in 2026: Which Crypto Wins
Bitcoin and Ethereum diverge in 2026 as institutions lean into regulated markets while Ethereum accelerates its settl...
Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Magnificent Dividend Stock Down 36%: Buy and Hold Forever
A down-market pullback can create a rare buying opportunity. This article explains how to spot a magnificent dividend...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status